Concomitant use of ciprofloxacin and diclofenac may cause elevated ciprofloxacin plasma concentrations. A pharmacokinetic study found increased ciprofloxacin exposure and levels when taken with diclofenac, along with decreased time to peak levels and total body clearance. Patients receiving these medications together should be monitored for increased ciprofloxacin side effects such as nervousness, nausea, and diarrhea.
Concomitant use of ciprofloxacin and diclofenac may cause elevated ciprofloxacin plasma concentrations. A pharmacokinetic study found increased ciprofloxacin exposure and levels when taken with diclofenac, along with decreased time to peak levels and total body clearance. Patients receiving these medications together should be monitored for increased ciprofloxacin side effects such as nervousness, nausea, and diarrhea.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Concomitant use of ciprofloxacin and diclofenac may cause elevated ciprofloxacin plasma concentrations. A pharmacokinetic study found increased ciprofloxacin exposure and levels when taken with diclofenac, along with decreased time to peak levels and total body clearance. Patients receiving these medications together should be monitored for increased ciprofloxacin side effects such as nervousness, nausea, and diarrhea.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
§ 2) Summary: In a single-dose pharmacokinetic study, coadministration of ciprofloxacin
and diclofenac resulted in increased ciprofloxacin exposure and plasma levels, and decreased ciprofloxacin Tmax and total body clearance (Iqbal et al, 2009). Although the clinical significance of this interaction is unknown, consider monitoring patients receiving these medications concomitantly for increased ciprofloxacin adverse events (nervousness, nausea, and diarrhea).
§ 3) Severity: moderate
§ 4) Onset: unspecified
§ 5) Substantiation: established
§ 6) Clinical Management: Concomitant use of ciprofloxacin and diclofenac may cause
elevated ciprofloxacin plasma concentrations (Iqbal et al, 2009). Monitor patients for increased ciprofloxacin adverse events (nervousness, nausea, and diarrhea).
§ 7) Probable Mechanism: unknown
Drug interactions Ciprofloxacin:
§ Metronidazole
§ a) Conflicting Data
§ 1) Incompatible
§ a) Ciprofloxacin 2 mg/mL with metronidazole 5 mg/mL, compatibility is
questionable; metronidazole concentration was reduced by about 10% immediately after mixing (Jim, 1993k); however, ciprofloxacin 1.67 mg/mL with metronidazole (ready to use) - 4.17 mg/mL, visually compatible and chemically stable for 48 hours in Dextrose 5% in water or Sodium chloride 0.9% at 4 or 25 degrees C (Goodwin et al, 1991f) § 2) Compatible § a) Ciprofloxacin 1.67 mg/mL with metronidazole (ready to use) - 4.17 mg/mL, visually compatible and chemically stable for 48 hours in Dextrose 5% in water or Sodium chloride 0.9% at 4 or 25 degrees C (Goodwin et al, 1991e); however, ciprofloxacin 2 mg/mL with metronidazole 5 mg/mL, compatibility is questionable; metronidazole concentration was reduced by about 10% immediately after mixing (Jim, 1993j)